Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis
Status:
Completed
Trial end date:
2020-01-09
Target enrollment:
Participant gender:
Summary
This is an open-label, multicenter study to evaluate the systemic exposure and safety of
topical tapinarof cream, 1% under conditions of maximal use in adults with plaque psoriasis.